Frozen shoulder at 51. Knees that suddenly complain on stairs. Tendons that flare after workouts that used to be easy. These cluster around the menopause transition for a physiological reason — and this is the one practice where the hormone side and the joint side are treated under one roof.
Estrogen receptors sit throughout your musculoskeletal system — cartilage, tendon, ligament, muscle, bone. When estrogen falls during the menopause transition, that whole system feels it: inflammation rises, tendons and ligaments lose elasticity, cartilage support weakens, and muscle mass becomes harder to keep.
In 2024, researchers gave this cluster a name: the musculoskeletal syndrome of menopause. Their review reports that more than 70% of women experience musculoskeletal symptoms during the transition, and roughly a quarter are significantly disabled by them. It includes:
None of this means the pain is "just hormones" — mechanical problems still need mechanical diagnosis. It means the hormonal context should be part of the evaluation, and in most orthopedic settings it never comes up.
The hormone side. Where clinically appropriate, hormone therapy addresses the estrogen-deficiency backdrop, alongside the strength training and bone-health work that midlife joints depend on. Medication is prescribed only when clinically appropriate after evaluation by a licensed clinician.
The joint side. Our parent practice is a therapeutic-injection clinic directed by a board-certified neurologist, with published pricing for the exact procedures this syndrome tends to need.
Targeted relief for the painful joint itself: shoulder injections (including frozen shoulder), knee and hip injections, tennis elbow and plantar fascia injections, and trigger point injections — every price published, performed by the same nurse practitioner you see for hormone care. Visit the main clinic →
Sometimes it helps substantially; sometimes the joint needs its own treatment; often the honest answer is both. Evidence on hormone therapy specifically for joint pain is still developing, so we treat the whole picture rather than promising a single fix.
Adhesive capsulitis peaks in women between roughly 40 and 60 — the menopausal window — and the shoulder capsule is rich in estrogen-sensitive connective tissue. The association is strong enough that new shoulder stiffness in midlife should always prompt the hormone conversation.
Not usually. Most midlife joint and tendon pain is managed without surgery. If your examination suggests something that needs imaging or a surgical opinion, we'll say so and point you to the right specialist.
Call or text and we'll find your slot. Online scheduling is coming soon.
Please keep health details out of text and email — save those for your visit. By texting us you consent to receive scheduling replies by SMS; reply STOP to opt out. If this is an emergency, call 911.